thalidomide has been researched along with Spinal Cord Neoplasms in 1 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Spinal Cord Neoplasms: Benign and malignant neoplasms which occur within the substance of the spinal cord (intramedullary neoplasms) or in the space between the dura and spinal cord (intradural extramedullary neoplasms). The majority of intramedullary spinal tumors are primary CNS neoplasms including ASTROCYTOMA; EPENDYMOMA; and LIPOMA. Intramedullary neoplasms are often associated with SYRINGOMYELIA. The most frequent histologic types of intradural-extramedullary tumors are MENINGIOMA and NEUROFIBROMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Complications from hemangioblastoma are among the principal causes of death from this syndrome." | 5.35 | Monotherapy with thalidomide for treatment of spinal cord hemangioblastomas in a patient with von Hippel-Lindau disease. ( Aricò, M; Buccoliero, AM; Genitori, L; Giordano, F; Mussa, F; Sanzo, M; Sardi, I, 2009) |
| "Complications from hemangioblastoma are among the principal causes of death from this syndrome." | 1.35 | Monotherapy with thalidomide for treatment of spinal cord hemangioblastomas in a patient with von Hippel-Lindau disease. ( Aricò, M; Buccoliero, AM; Genitori, L; Giordano, F; Mussa, F; Sanzo, M; Sardi, I, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sardi, I | 1 |
| Sanzo, M | 1 |
| Giordano, F | 1 |
| Buccoliero, AM | 1 |
| Mussa, F | 1 |
| Aricò, M | 1 |
| Genitori, L | 1 |
1 other study available for thalidomide and Spinal Cord Neoplasms
| Article | Year |
|---|---|
Monotherapy with thalidomide for treatment of spinal cord hemangioblastomas in a patient with von Hippel-Lindau disease.
Topics: Angiogenesis Inhibitors; Child; Female; Hemangioblastoma; Humans; Spinal Cord Neoplasms; Thalidomide | 2009 |